Skip to main content
Equibles

Squarepoint Ops LLC

Position in DHR — Danaher Corp /De/

CIK 1642575 NEW YORK, NY
Back to DHR Full portfolio

Position in DHR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$115,756,488
+$54,691,392 QoQ
Shares Held
610,530
+128.9% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Derivatives in DHR

reported options exposure · as of Mar 31, 2026
CallValue
$12,305,040
CallShares
64,900
PutValue
$2,483,760
PutShares
13,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $504,966,896 across 26 Diagnostics & Research names. DHR ranks #1 (22.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DHR
Danaher Corp /De/
This page 		610,530 $115,756,488
2 A
Agilent Technologies, Inc.
 926,259 $105,575,000
3 DGX
Quest Diagnostics Inc
 345,788 $67,767,532
4 IDXX
Idexx Laboratories Inc /De
 100,309 $56,362,624
5 LH
Labcorp Holdings Inc.
 140,165 $37,397,423
6 TMO
Thermo Fisher Scientific Inc.
 69,837 $34,326,980
7 MEDP
Medpace Holdings, Inc.
 58,875 $28,271,186
8 GH
Guardant Health, Inc.
 191,740 $17,711,023

All Filings in DHR

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,305,040 64,900
2026-03-31 $115,756,488 610,530
2026-03-31 $2,483,760 13,100
2025-12-31 $61,065,096 266,753
2025-12-31 $22,754,648 99,400
2025-12-31 $206,028 900
2025-09-30 $93,849,344 473,365
2025-09-30 $713,736 3,600
2025-09-30 $87,630,920 442,000
2025-06-30 $6,301,526 31,900
2025-06-30 $37,532,600 190,000
2025-06-30 $51,436,255 260,384
2025-03-31 $55,141,310 268,982
2025-03-31 $4,694,500 22,900
2025-03-31 $26,465,500 129,100
2024-12-31 $15,267,600 66,511
2024-12-31 $9,411,550 41,000
2024-12-31 $13,199,125 57,500
2024-09-30 $15,569,120 56,000
2024-09-30 $4,114,696 14,800
2024-09-30 $4,811,414 17,306
2024-06-30 $19,381,364 77,572
2024-06-30 $24,685,180 98,800
2024-06-30 $11,643,010 46,600
2024-03-31 $52,915,668 211,900
2024-03-31 $12,960,468 51,900
2024-03-31 $14,313,450 57,318
2023-12-31 $3,493,234 15,100
2023-12-31 $3,446,966 14,900
2023-12-31 $19,230,368 83,126
2023-09-30 $15,591,588 70,888
2023-06-30 $10,085,108 47,400
2023-06-30 $7,851,065 36,900
2023-06-30 $31,820,219 149,555
2023-03-31 $64,041,616 286,617
2023-03-31 $5,831,776 26,100
2023-03-31 $3,440,971 15,400
2022-12-31 $3,129,508 13,300
2022-12-31 $752,964 3,200
2022-12-31 $48,654,446 206,775
2022-06-30 $202,276 900
2022-03-31 $6,730,466 25,882
2022-03-31 $182,031 700
2021-12-31 $4,783,478 16,400
2021-12-31 $4,200,127 14,400
2021-12-31 $24,481,491 83,934
2021-09-30 $4,480,233 16,600
2021-09-30 $3,940,446 14,600
2021-09-30 $4,553,105 16,870
2021-06-30 $6,263,398 26,327

Report a Problem

Category
Description
Email (optional, for follow-up)